1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Food Allergy: new trials by email Literature Review of Food Allergy trials Research Report on Food Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Extension Study of Ligelizumab in Food Allergy Ligelizumab 120 mg, Ligelizumab 240 mg - Food Allergy | Phase 3 | Terminated | Novartis Pharmaceuticals | 163 | 2023-04-27 | 2026-01-13 |
Food Hypersensitivity (1) · Peanut Hypersensitivity (1)
Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Nut and Peanut Hypersensitivity (1)
ligelizumab (1)
Australia (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United States (1)